NYU Langone names Shohei Koide to lead new biologics research program

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

NYU LANGONE MEDICAL CENTER established a program in biologics research, appointing Shohei Koide to lead the new initiative. Koide will join NYU Langone March 1, 2016 as director of cancer biologics at the Laura and Isaac Perlmutter Cancer Center. “No other academic medical institution on the East Coast has a major presence in biologics research,”...

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe

YOU MAY BE INTERESTED IN

Confidential Trump administration budget documents show that the upcoming FY26 Budget Request will radically cut about $50 billion out of the U.S. Department of Health and Human Services, reshuffling agency components, and slashing the number of NIH institutes and centers to just eight. 
As he addressed FDA employees, HHS Secretary Robert F. Kennedy Jr. described the Trump era as a “generational opportunity to make the regulatory agency live up to its foundational ideals” and emerge from the morass of what he described as the “deep state.”

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login